OMICS Publishing Group: An Open Access Publisher
  » Publications A-Z index   » Browse by subject   » Conferences
 



 
 
Omics Publishing Group  
 
Download Journal Flier
Journal of Nanomedicine & Biotherapeutic Discovery
   
 Journal of Nanomedicine & Biotherapeutic Discovery
Application of nanotechnology in medical field is nothing but Nanomedicine. Nanomedicine desires to deliver a precious set of research tools and clinically reformative devices in the near future.
   
 Open Access
Journal of Nanomedicine & Biotherapeutic Discovery (JNBD) is an international, peer-reviewed journal. Each issue of JNBD presents basic, clinical, and engineering research in the field of nanomedicine and the related biotherapeutic discovery. The regular features address the commercialization of nanomedicine advances, ethics in nanomedicine, funding opportunities, and other topics of interest to researchers and clinicians.
   
 Objectives
The main objective of JNBD is to bring forth the synergy between the biotherapeutic strategies and biological evaluations in nanomedicine through new and significant contributions from active researchers in the field.
   
 Editorial Manager
JNBD is using online manuscript submission, review and tracking systems of Editorial Manager® for quality and quick review processing.  Review processing is performed by the editorial board members of JNBD or outside experts; at least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript.
   
 International Prospectives
The Journal is an integral part of the international debate on moving to a health care system that emphasizes prediction, personalization, and prevention, while continuing to improve treatments for end stage diseases.
 
 
Applying for a waiver or discount please e-mail(info@omicsonline.org) to the managing editor with proposed title and abstract.
Journal of Nanomedicine& Biotherapeutic Discovery
ISSN: 2155-983X
OMICS Publishing Group: An Open Access Publisher
OMICS Publishing Group is the member of/publishing partner of/source content provider to
All Published content, except where otherwise noted, is licensed under a Creative Commons Attribution License.